35150008: Glucocorticoid hormone (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2024. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glucocorticoid hormone	Is a	Corticosteroid and/or corticosteroid derivative	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Glucocorticoid hormone	Is a	Adrenal cortex hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Glucocorticoid hormone	Is a	Steroid hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Glucocorticoid hormone	Is a	Glucocorticoid (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Glucocorticoid hormone	Has disposition	Adrenal cortex hormone (disposition)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulphate 1mg/3.5mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + tobramycin 0.1%wv/0.3%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + tobramycin 1mg/3mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone sodium phospha + lidocaine hydrochloride 0ns/10mg (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Gentamicin sulfate + prednisolone acetate 0ns/0.6%ww ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Gentamicin sulfate + prednisolone acetate 0ns/10%vv suspension (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Nystatin + triamcinolone acetonide 100000unt/1mg cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Nystatin + triamcinolone acetonide 100000unt/1mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Nystatin + triamcinolone acetonide 10000unt/1mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone+calcipotriol (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone 3 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely prednisone 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone sodium phosphate 0.05% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone- and neomycin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone sodium phosphate 24mg injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone sodium phosphate 4mg injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone sodium phospha 10mg injection solution vial (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Gentamicin sulfate + prednisolone acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
médicament contenant dexaméthasone et néomycine et polymyxine B	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing dexamethasone sodium phosphate and neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 3mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone sodium phosphate 20mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone sodium phosphat 20mg/mL injection solution 10mL vial (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone hexacetonide 20mg/mL injection suspension 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate 50mg/mL injection suspension 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone hexacetonide 5mg/mL injection suspension 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone sodium phosphat 20mg/mL injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone acetate 50mg/mL injection suspension 30mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing prednisolone sodium phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Prednisolone 20mg/100mL enema	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone 40mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone 80mg/2mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing desoximetasone and salicylic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing betamethasone and clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous foam (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Desonide 500 microgram/g cutaneous gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 250 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 1 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 5 mg/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 1 mg/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 1 mg/mL cutaneous lotion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
17-ketogenic steroid	Is a	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Medrysone ophthalmic preparation	Is a	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)
Tetrahydrocorticosterone	Is a	False	Glucocorticoid hormone	Inferred relationship	Existential restriction modifier (core metadata concept)

Start Previous Page 5 of 5

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

POSSIBLY EQUIVALENT TO association reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
58652012	Glucocorticoid hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
766757010	Glucocorticoid hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
58652012	Glucocorticoid hormone	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
58652012	Glucocorticoid hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
766757010	Glucocorticoid hormone (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
766757010	Glucocorticoid hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core